Cargando…
Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia
BACKGROUND: The persistence of minimal residual disease (MRD) during therapy is the strongest adverse prognostic factor in acute lymphocytic leukemia (ALL). This study was to identify serum candidate peptides for monitoring MRD in adult ALL. RESULTS: A total of 33 peptides in the molecular weight ra...
Autores principales: | Bai, Ju, He, Aili, Huang, Chen, Yang, Juan, Zhang, Wanggang, Wang, Jianli, Yang, Yun, Zhang, Pengyu, Zhang, Yang, Zhou, Fuling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195909/ https://www.ncbi.nlm.nih.gov/pubmed/25317080 http://dx.doi.org/10.1186/s12953-014-0049-y |
Ejemplares similares
-
Correction to: Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia
por: Bai, Ju, et al.
Publicado: (2020) -
Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling
por: Bai, Ju, et al.
Publicado: (2013) -
Serum peptidomic profiling identifies a minimal residual disease detection and prognostic biomarker for patients with acute leukemia
por: SONG, WEI, et al.
Publicado: (2013) -
C59T mutation in exon 2 of monocytic leukemia-associated antigen-34 gene indicates a high risk of recurrence of acute myeloid leukemia
por: Lei, Bo, et al.
Publicado: (2017) -
Prokaryotic expression of MLAA-34 and generation of a novel human ScFv against MLAA-34 by phage display technology
por: Zhang, Yang, et al.
Publicado: (2017)